Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome

Annals of Allergy, Asthma and Immunology

Volumn 113, Issue 6, 2014, Pages 652-657

  Lim, Hyo Seok ^a,b   Choi, Sun Mi ^a,b   Lee, Jinwoo ^a,b   Park, Yong Sik ^a,b   Lee, Sang Min ^a,b   Yim, Jae Joon ^a,b   Yoo, Chul Gyu ^a,b   Kim, Young Whan ^a,b   Han, Sung Koo ^a,b   Lee, Chang Hoon ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; ASTHMA; ASTHMA CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SOUTH KOREA; TREATMENT RESPONSE; COMPLICATION; DRUG COMBINATION; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; ASTHMA; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84919848076     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.08.021     Document Type: Article

References (29)

1. J.B. Soriano, K.J. Davis, B. Coleman, G. Visick, D. Mannino, and N.B. Pride The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom Chest 124 2003 474 481
2. A.A. Zeki, M. Schivo, A. Chan, T.E. Albertson, and S. Louie The asthma-COPD overlap syndrome: a common clinical problem in the elderly J Allergy 2011 2011 861926
3. P.G. Gibson, and J.L. Simpson The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 64 2009 728 735
4. A.M. Menezes, M. Montes de Oca, and R. Pérez-Padilla Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma Chest 145 2014 297 304
5. A. Shambhu, D.G. Enrique, and M.M. David Treatment options in asthma and chronic obstructive pulmonary disease overlap syndrome Eur Respir Dis 7 2011 101 105
6. M. Miravitlles, J.J. Soler-Cataluna, and M. Calle Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery Arch Bronconeumol 48 2012 247 257
7. D.E. O'Donnell, S. Aaron, and J. Bourbeau Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Can Respir J 14 suppl B 2007 5B 32B
8. [COPD guideline by the Japanese Society of Respiratory Society. Guideline of diagnosis and treatment of COPD (chronic obstructive lung disease)] Nihon Kokyuki Gakkai Zasshi suppl 1999 1 95
9. National Asthma Education and Prevention Program Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007 J Allergy Clin Immunol 120 2007 S94 S138
10. S. Louie, A.A. Zeki, and M. Schivo The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations Expert Rev Clin Pharmacol 6 2013 197 219
11. B.R. Celli, W. MacNee, and A.E.T. Force Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
12. D. Cockcroft, and B. Davis Direct and indirect challenges in the clinical assessment of asthma Ann Allergy Asthma Immunol 103 2009 363 369 quiz 369-372, 400
13. J. Vestbo, L.D. Edwards, and P.D. Scanlon Changes in forced expiratory volume in 1 second over time in COPD N Engl J Med 365 2011 1184 1192
14. J.M. Fernando, F.D. James, and I.R. Stephen The future of chronic obstructive pulmonary disease treatment - difficulties of and barriers to drug development Lancet 378 2011 1027 1037
15. P.M. Calverley, J.A. Anderson, and B. Celli Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
16. D.P. Tashkin, B. Celli, and S. Senn A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
17. Y. Kitaguchi, Y. Komatsu, K. Fujimoto, M. Hanaoka, and K. Kubo Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma Int J Chron Obstruct Pulmon Dis 7 2012 283 289
18. P.S. Burge, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, and T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 2000 1297 1303
19. R.A. Pauwels, C.G. Lofdahl, and L.A. Laitinen Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease N Engl J Med 340 1999 1948 1953
20. J. Vestbo, T. Sorensen, P. Lange, A. Brix, P. Torre, and K. Viskum Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial Lancet 353 1999 1819 1823
21. M.B. Drummond, E.C. Dasenbrook, M.W. Pitz, D.J. Murphy, and E. Fan Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis JAMA 300 2008 2407 2416
22. S. Singh, A.V. Amin, and Y.K. Loke Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis Arch Intern Med 169 2009 219 229
23. I.A. Yang, M.S. Clarke, E.H. Sim, and K.M. Fong Inhaled corticosteroids for stable chronic obstructive pulmonary disease Cochrane Database Syst Rev 7 2012 CD002991
24. D.D. Sin, F.A. McAlister, S.F. Man, and N.R. Anthonisen Contemporary management of chronic obstructive pulmonary disease: scientific review JAMA 290 2003 2301 2312
25. P. Calverley, R. Pauwels, and J. Vestbo Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial Lancet 361 2003 449 456
26. W. Szafranski, A. Cukier, and A. Ramirez Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease Eur Respir J 21 2003 74 81
27. H.Y. Park, S.F. Man, and D.D. Sin Inhaled corticosteroids for chronic obstructive pulmonary disease BMJ 345 2012 e6843
28. A. Papi, M. Romagnoli, and S. Baraldo Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 1773 1777
29. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281